EUVIMEDEUVIMED entdecken
Crossref

The role of a local application of 10% doxycycline gel in the prevention of medication-related osteonecrosis of the jaw in rats

Henrique Hadad, Laís Kawamata de Jesus, Maísa Pereira-Silva, Maria Eduarda de Freitas Santana Oliveira, Naara Gabriela Monteiro, Pier Paolo Poli, Carlo Maiorana, Roberta Okamoto, Fernando Pozzi Semeghini Guastaldi, Juliano Milanezi de Almeida, Francisley Ávila Souza

Clinical Oral Investigations · 2025

DOI: 10.1007/s00784-025-06279-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Oral Investigations, 2025. Verfasst von Henrique Hadad und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnosis and Surgery, Oral & Maxillofacial Surgery Division, School of Dentistry, São Paulo State University (UNESP), 1193 José Bonifá…. Hauptthemen laut MEDLINE: Doxycycline, Bisphosphonate-Associated Osteonecrosis of the Jaw, Anti-Bacterial Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 55 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: This study aimed to evaluate doxycycline on the prevention of MRONJ. MATERIALS AND METHODS: Seventy-two Wistar rats were sorted into 3 groups and subjected to tooth extractions. The first group received systemic saline solution (SAL), the second received zoledronic acid (ZA), and the third, besides the systemic ZA, the post-extraction socket received local application of doxycycline (DOXI) gel. Samples were collected and analyzed at 7, 14, and 28 postoperative days. RESULTS: DOXI group presented higher percentage of vital bone area as compared with ZA at 7 (p = 0.0058), 14 (p < 0.0001), and 28 days (p < 0.0001). TRAP immunolabeling was lower in ZA and DOXI at 7 and 14 days, while OCN immunolabeling was similar between the ZA and DOXI, except at 7 days. At 14 and 28 days, DOXI group presented more collagen type 3 and 1 (p < 0.0001) as compared with ZA. RUNX2, ALP, OCN, and RANKL gene expression was downregulated in ZA at 7 days. Conversely, DOXI upregulated these markers and OPG over time (p < 0.05). CONCLUSION: Doxycycline is an effective local agent for preventing MRONJ, favoring alveolar bone healing. CLINICAL RELEVANCE: Although widely studied, MRONJ remains a significant challenge in dentistry. The search for preventive methods is important to assure safety for in patients under antiresorptive therapy that demand surgical dental treatment. Doxycycline is well-established in dentistry, and the proposal of using this medication as a gel makes it more appealing since it is applied locally and has negligible adverse effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxycyclineBisphosphonate-Associated Osteonecrosis of the JawAnti-Bacterial AgentsAnimalsRats, WistarRatsZoledronic AcidGelsTooth ExtractionMaleBone Density Conservation AgentsDiphosphonatesImidazolesImmunohistochemistryAdministration, Topical

Stichwörter der Autor:innen

Antiresorptive drugsBisphosphonatesBone repairDoxycyclineMRONJ

Substanzen

DoxycyclineZoledronic AcidGelsBone Density Conservation AgentsAnti-Bacterial AgentsDiphosphonatesImidazoles

Autor:innen und Institutionen

  • Department of Diagnosis and Surgery, Oral & Maxillofacial Surgery Division, School of Dentistry, São Paulo State University (UNESP), 1193 José Bonifácio St, Araçatuba, SP, 16015-050, Brazil. henriquehadad@gmail.com.
  • Department of Diagnosis and Surgery, Oral & Maxillofacial Surgery Division, School of Dentistry, São Paulo State University (UNESP), 1193 José Bonifácio St, Araçatuba, SP, 16015-050, Brazil.
  • Department of Basic Sciences, School of Dentistry, São Paulo State University (UNESP), Araçatuba, SP, Brazil.
  • Implant Center for Edentulism and Jawbone Atrophies, Maxillofacial Surgery and Odontostomatology Unit, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Department of Biomedical, Surgical and Dental Sciences, University of Milan, Milan, Italy.
  • Department of Oral and Maxillofacial Surgery, Massachusetts General Hospital, Harvard School of Dental Medicine, Boston, MA, USA.

Zitieren

APA

Hadad, H., de Jesus, L. K., Pereira-Silva, M., Oliveira, M. E. F. S., Monteiro, N. G., Poli, P. P., Maiorana, C., Okamoto, R., Guastaldi, F. P. S., de Almeida, J. M., & Souza, F. Á. (2025). The role of a local application of 10% doxycycline gel in the prevention of medication-related osteonecrosis of the jaw in rats. Clinical Oral Investigations. https://doi.org/10.1007/s00784-025-06279-4

Vancouver

Hadad H, de Jesus LK, Pereira-Silva M, Oliveira MEFS, Monteiro NG, Poli PP, et al. The role of a local application of 10% doxycycline gel in the prevention of medication-related osteonecrosis of the jaw in rats. Clinical Oral Investigations. 2025. doi:10.1007/s00784-025-06279-4

BibTeX
@article{Hadad2025,
  author = {Hadad, Henrique and de Jesus, Laís Kawamata and Pereira-Silva, Maísa and Oliveira, Maria Eduarda de Freitas Santana and Monteiro, Naara Gabriela and Poli, Pier Paolo and Maiorana, Carlo and Okamoto, Roberta and Guastaldi, Fernando Pozzi Semeghini and de Almeida, Juliano Milanezi and Souza, Francisley Ávila},
  title = {The role of a local application of 10% doxycycline gel in the prevention of medication-related osteonecrosis of the jaw in rats},
  journal = {Clinical Oral Investigations},
  year = {2025},
  doi = {10.1007/s00784-025-06279-4}
}
Kostenlos starten →